強気
$14.53
シナリオ価格
$12.200
-0.010 (-0.08%)終値時点
Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.
Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Aimei Health Terminates Merger Agreement with United Hydrogen

Aimei Health Terminates Merger Agreement with United Hydrogen

Aimei Health Technology Terminates Business Combination Agreement

Aimei Health Technology Fails to File Quarterly Report on Time

WhiteFiber Inc (WYFI) Announces $200 Million Convertible Notes Offering, Shares Drop 5.5%
Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues. It operates in the Financials sector.
Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。